AstraZeneca Loses Bid To Ban Seroquel MDL Expert
A judge in charge of multidistrict litigation over AstraZeneca's antipsychotic drug Seroquel has denied a request by the drugmaker to exclude the general causation testimony of an expert witness for plaintiffs....To view the full article, register now.
Already a subscriber? Click here to view full article